NMR spectroscopy is a highly versatile and powerful biophysics method vital for structural and chemical analysis of small-molecule chemical compounds. Funding is sought to support acquisition of a state-of-the- art Bruker AVANCE NEO 400 MHz NMR spectrometer at the Icahn School of Medicine at Mount Sinai. The proposed NMR spectrometer system will be configured with a high performance AVANCE NEO console and equipped with a high-sensitivity X-nuclei-optimized double resonance broad banded Cryo-probe ProdigyTM and an automatic NMR sample changer (SampleCase). This new NMR system will be available to all investigators at the Icahn School of Medicine at Mount Sinai, and will greatly enhance the essential NMR spectroscopy needs for NIH-funded chemical biology and drug discovery research projects by major users in their pursuit of discovery of fundamental molecular mechanisms of biology and development of new treatments for human diseases.

Public Health Relevance

Our goal is to acquire a state-of-the-art Bruker 400 MHz NMR spectrometer system at Icahn School of Medicine at Mount Sinai to provide enhanced support for our NIH-funded chemical biology and drug discovery research studies.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
Biomedical Research Support Shared Instrumentation Grants (S10)
Project #
1S10OD028504-01
Application #
9939195
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Wang, Guanghu
Project Start
2020-06-01
Project End
2021-05-31
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
1
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Pharmacology
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029